Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan

PHASE3CompletedINTERVENTIONAL
Enrollment

341

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Bacterial Meningitis
Interventions
BIOLOGICAL

Meningococcal ACWY conjugate vaccine

All subjects received a single dose of Meningococcal ACWY conjugate vaccine and had blood draw at day 1 and day 29.

Trial Locations (3)

10002

Mackay Memorial Hospital,, Taipei

National Taiwan University Hospital, Taipei

22060

Far Eastern Memorial Hospital,, Taipei

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY